@ndavidtg

Intensive Care Physician - Liver ICU at Hospital Clínic de Barcelona. Associate Professor at the University of Barcelona.

 Barcelona, Spain
cursosmedicinaintensiva.ub.edu/postgrados/fhc/
Joined July 2010
  • Tweets837
  • Following1.1K
  • Followers352
38Media
Abiertas las inscripciones al Postgrado en Fundamentos de Hepatología Crítica Dirigido a especialistas interesados en el manejo avanzado del paciente hepático crítico. cursosmedicinaintensiva.ub.e… #Hepatology #CriticalCare @LiverIcu @hospitalclinic @UniBarcelona @mecs_ub
29
N. David Toapanta G. retweeted
Gaudry@StephaneG05Oct 14
Proud to share the publication of the ICRAKI trial in the @NEJM In critically ill patients with AKI requiring RRT, intermittent hemodialysis was associated with higher mortality than CRRT. thanks to all participating teams for their outstanding commitment #ICRAKI #NEJM #AKI
7
31
133
6,926
El curso Tratamiento del paciente hepático crítico combina actualización clínica y simulación práctica sobre insuficiencia hepática aguda grave, ACLF, shock séptico, insuficiencia renal y trasplante, y otros aspectos clave. Inscripciones: aulaclinic.com/cursos/view.p…
2
2
204
Post-liver transplantation delirium: Pathogenesis, risk factors, clinical management, and future directions journals.lww.com/lt/abstract…
5
10
897
N. David Toapanta G. retweeted
NEJM
@NEJMJun 11
Presented at #CCR26: Among adults with septic shock, the use of restricted fluids and early vasopressors did not result in more days alive and out of the hospital through day 90 than the use of liberal fluids and later vasopressors. Full ARISE FLUIDS trial results: nej.md/3PVdwIp @CritCareReviews
A graph from an article titled "Vasopressors or Fluids in Early Septic Shock," which was presented at the Critical Care Reviews Meeting. The trial name "ARISE FLUIDS" appears in parentheses with the title. The x-axis shows days 0 to 90, and the y-axis represents the percentage of patients. Two lines indicate the percentage for vasopressors and fluids.

ALT A graph from an article titled "Vasopressors or Fluids in Early Septic Shock," which was presented at the Critical Care Reviews Meeting. The trial name "ARISE FLUIDS" appears in parentheses with the title. The x-axis shows days 0 to 90, and the y-axis represents the percentage of patients. Two lines indicate the percentage for vasopressors and fluids.

1
82
8
232
31,216
¿Te interesa la hepatología crítica? Nos gustaría compartir con vosotros una nueva edición del curso “Tratamiento del Paciente Hepático Crítico”. 📅 8–9 octubre 2026 | Barcelona Inscripciones abiertas aulaclinic.com/media/upload/… – at Barcelona, Spain
2
76
SAVE THE DATE | 8–9 Oct 2026 Curso “Tratamiento del paciente hepático crítico” Advanced management of ALF, ACLF and Liver Transplantation with extracorporeal liver support, CRRT and clinical simulation. 📍 Barcelona | CEK & Universitat de Barcelona @LiverIcu @hospitalclinic
32
¿Te interesa el manejo del paciente hepático crítico? Próximamente iniciaremos la fase de preinscripción para la edición 2026–2027 del Postgrado de Fundamentos de Hepatología Crítica de la UB postgradosub.web.app/fhc/ @hospitalclinic @UniBarcelona @semicyuc @SOCMIC @AEEHLiver
3
47
Liver Transplantation in Alcohol-Related Liver Disease | New England Journal of Medicine www-nejm-org.sire.ub.edu/doi… ¿Trasplante hepático precoz en enfermedad hepática alcohólica? Debate abierto. @LiverIcu @SOCMIC @semicyuc
2
38
N. David Toapanta G. retweeted
JAMA
@JAMA_current11 Nov 2025
In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment. ja.ma/4hToPu9
JAMA study: Conservative dialysis improves kidney function recovery in AKI patients needing dialysis. 148 men, 72 women, mean age 56. Conservative strategy: 64% recovery vs. Conventional dialysis: 50%.

ALT JAMA study: Conservative dialysis improves kidney function recovery in AKI patients needing dialysis. 148 men, 72 women, mean age 56. Conservative strategy: 64% recovery vs. Conventional dialysis: 50%.

1
4
28
6,249
IV Jornada del Grupo de Trabajo de Patología Digestiva Crítica Soporte renal en el hepático crítico: qué, cuándo y cómo? 🗓️ Miércoles, 3 de diciembre de 2025 | 17:00 h 📍 Hospital Universitari de Bellvitge inscripcions.academia.cat/fo… @SOCMIC @semicyuc @LiverIcu @hbellvitge
2
1
117
N. David Toapanta G. retweeted
JAMA
@JAMA_current10 Nov 2025
The most common chronic liver disease worldwide, metabolic dysfunction–associated steatotic liver disease (MASLD) affects approximately 30% to 40% of the general adult population. This Review summarizes the diagnosis, treatment, and prognosis of MASLD. ja.ma/47ytEFC
Figure outlines MASLD progression from healthy liver to cirrhosis/hepatic decompensation. Factors promoting MASLD include diet, insulin resistance; protective factors: physical exercise, socioeconomic status. Progression rates are shown. Text: JAMA, Published online November 10, 2025.

ALT Figure outlines MASLD progression from healthy liver to cirrhosis/hepatic decompensation. Factors promoting MASLD include diet, insulin resistance; protective factors: physical exercise, socioeconomic status. Progression rates are shown. Text: JAMA, Published online November 10, 2025.

1
135
3
425
45,385
N. David Toapanta G. retweeted
Fede Gordo-Vidal@ventilacionmeca7 Nov 2025
Avances en el soporte hepático extracorpóreo en la insuficiencia hepática aguda y aguda sobre crónica medintensiva.org/es-advances…
13
39
2,529
🥼 XXX Reunión de la Asociación de Medicina Intensiva de la Comunidad de Madrid. XVII Jornadas madrileñas de atención al paciente crítico. ✅ Patologia abdominal crítica o la medicina intensiva fuera de la UCI son dos de los muchos temas a tratar. +info. c.madrid/dbj3p1
2
10
1
11
1,311
N. David Toapanta G. retweeted
SEMICYUC@semicyuc3 Nov 2025
El número de noviembre de la revista Medicina Intensiva ya está disponible. Accede a sus contenidos y no te pierdas ningún contenido. Disponible en la web y desde la app. bit.ly/4hIMai0 #medicinaintensiva #divulgación @intensiva_med
5
11
814
N. David Toapanta G. retweeted
SEMICYUC@semicyuc28 Oct 2025
El Periódico explica con la ayuda de los doctores Eva Santafosta (GT Patología Digestiva Crítica) y Borja Suberviola (GTEIS) qué es la pancreatitis aguda necrotizante. elperiodico.com/es/salud/202… #intensivistas #losprofesionalesdelenfermocrítico

Qué es la pancreatitis aguda necrotizante, la enfermedad que sufre el profesor cordobés ingresado...

La doctora Eva María Santafosta explica que la pancreatitis aguda necrotizante puede causar infección y el fallo de órganos vitales como los pulmones, los riñones o el corazón.

elperiodico.com
3
1
373
✅ Let's spread life-saving Science with the new ERC Guidelines launched during the ERC Congress. 💯 💙 Please read them, download them from the website or download the ERC Guidelines App by scanning the QR Code below, save lives and become part of the life-saving community. ❤️ Website: 👉 erc.edu/download-centre/ #ERC #Guidelines2025 #ERCGuidelines #savelives #RestartAHeart #StrongerTogether
25
42
3,782
💙 Keep updated with this important information about the Joint Guidelines launch of the Guidelines on Cardiopulmonary Resuscitation 2025, on October 22, 2025, in Rotterdam. This event is a collaborative effort between the ERC, AHA, ILCOR. ❤️ All the different sessions will be made available via livestream in parallel, and at no cost to the viewer. ✅ Read the news and click the embedded links to access the livestreams of each session here 👉 erc.edu/news/save-the-date-o…. ✅ These livestream events do not require pre-registration #ERC #AHA #ILCOR #RESUS25 #ERCGuidelines #Guidelines2025 #savethedate #savelives #StrongerTogether #Resuscitation
6
40
6
83
9,296
🗓️ 8 octubre · 17h Sesión virtual Pancreatitis y Patología Digestiva Crítica (@semicyuc) @SOCMIC Un punto de encuentro para seguir avanzando en #MedicinaIntensiva. ℹ️ pagos.semicyuc.net/producto/… #UCI #SEMICYUC
23
N. David Toapanta G. retweeted
SEMICYUC@semicyuc11 Sep 2025
El Grupo de Trabajo de Patología Digestiva Crítica de la #SEMICYUC firma 'Avances en el soporte hepático extracorpóreo en la insuficiencia hepática aguda y aguda sobre crónica'. ▶ Revisión que resume de manera práctica el papel de las terapias de soporte hepático extracorpóreo en la insuficiencia hepática aguda y aguda sobre crónica. ▶ Disponible pre-print en @intensiva_med 👉 medintensiva.org/en-advances… #medicinaintensiva
2
9
825
Load more